Pseudohyponatremia in a patient with HIV and hepatitis C coinfection

Journal of General Internal Medicine

Volumn 23, Issue 2, 2008, Pages 202-205

  Garibaldi, Brian T ^a   Cameron, Scott J ^a   Choi, Michael ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Electrolyte exclusion effect; Hepatitis C; HIV; Pseudohyponatremia

Indexed keywords

LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT;

ADULT; ARTICLE; BLOOD GAS ANALYSIS; CASE REPORT; CLINICAL FEATURE; ELECTROLYTE DISTURBANCE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LIVER CIRRHOSIS; MALE; PATHOGENESIS; PATIENT CARE; PHYSICAL EXAMINATION; PSEUDOHYPONATREMIA; RESUSCITATION;

BLOOD PROTEIN DISORDERS; FALSE POSITIVE REACTIONS; FIBROSIS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; HYPONATREMIA; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION;

EID: 39149094640     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0446-3     Document Type: Article

References (15)

1. Tietz NW, Pruden EL, Siggaard-Andersen O. Electrolytes. In: Burtis CA, Ashwood ER, eds. Tietz Fundamental of Clinical Chemistry, 4th ed. Philadelphia, PA: WB Saunders; 1996:497-505.
2. Nguyen MK, Ornekian V, Butch AW, Kurtz I. A new method for determining plasma water content: application in pseudohyponatremia. Am J Physiol Renal Physiol. 2007;292(5):F1652-6.
3. Weisberg LS. Pseudohyponatremia: a reappraisal. Am J Med. 1989;86:315-8.
4. Turchin A, Seifter JL, Seely EW. Mind the gap. N Engl J Med. 2003;349:1465-9.
5. Frier BM, Steer CR, Baird JD, Bloomfield S. Misleading plasma electrolytes in diabetic children with severe hyperlipidaemia. Arch Dis Child. 1980;55:771-5.
6. Waugh WH. Utility of expressing serum sodium per unit of water in assessing hyponatremia. Metabolism. 1969;18(8):706-12.
7. Grateau G, Bachmeyer C, Taulera O, Sarfati G, Cremer G, Sereni D. Pseudohyponatremia and pseudohyperphosphatemia in a patient with human immunodeficiency virus infection. Nephron. 1993;64(4):640.
8. Abelian A, Burling K, Easterbrook P, Winter G. Hyperimmunoglobulinemia and rate of HIV type 1 infection progression. AIDS Res Hum Retroviruses. 2004;20(1):127-8.
9. Shirai A, Cosentino M, Leitman-Klinman S, Klinman D. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest. 1992;89(2):561-6.
10. Binley JM, Klasse PJ, Cao Y, Jones I, Markowitz M, Ho DD, Moore JP. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol. 1997;71(4):2799-809.
11. Morris L, Binley JM, Clas BA, et al. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med. 1998;188(2):233-45.
12. Genesca J, Gonzalez A, Torregrosa M, Mujal A, Segura R. High levels of endotoxin antibodies contribute to hyperglobulinemia of cirrhotic patients. Am J Gastroenterol. 1998;93(4):664-5.
13. Morsica G, Tambussi G, Sitia G, et al. Replication of hepatitis C virus in B lymphocytes (CD19+). Blood. 1999;94(3):1138-9.
14. Zignego AL, Brechot C. Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol. 1999;31(2):369-76.
15. Soriano-Sarabia N, Leal M, Delgado C, et al. Effect of hepatitis C virus coinfection on humoral immune alterations in naive HIV-infected adults on HAART: a three year follow-up study. J Clin Immunol. 2005;25(3):296-302.